K-numberK252029
Device nameAI-CVD
ApplicantHeartLung Corporation
Product codeQIH
Device classClass II
Decision dateDec 19, 2025
DecisionSubstantially Equivalent
Regulation892.2050
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

AI-CVD® is an AI-powered software tool that automatically analyzes CT scans to provide quantitative measurements of cardiovascular, pulmonary, and metabolic features including coronary artery calcium scores, cardiac chamber volumes, epicardial fat, aortic and valve calcifications, lung density, liver density, bone mineral density, and muscle/fat composition. It is intended to aid healthcare providers in identifying patients at risk for various conditions to support preventive care planning, but does not provide diagnostic interpretation or risk prediction itself.

Technological characteristics

AI-CVD® uses deep learning-based segmentation built on the open-source TotalSegmentator framework with nnU-Net architecture, trained on contrast-enhanced and non-contrast CT scans. Like the predicate devices, it automatically defines regions of interest, measures volumes and densities within those regions, operates on DICOM CT images, and requires human expert review and approval of segmentation results. The device runs on Linux and performs retrospective measurements from existing CT scans.

Test standards cited

Not stated in this summary.

Substantial equivalence argument

AI-CVD® is substantially equivalent to its predicate device AutoChamber® (K240786) and reference device Auto-BMD (K213760) because it performs the same intended function of providing automated quantitative imaging measurements from CT scans using similar technological approaches (deep learning segmentation, automatic ROI definition, volume and density measurement, human expert review). Clinical validation through retrospective analysis of large population cohorts (MESA and FHS) demonstrated comparable safety and effectiveness to manual expert measurements and gold standard reference tests, with no new safety or effectiveness issues raised.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →